Henk J. Broxterman
Amsterdam, NH 1081HV, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Effects of Cancer Presence and Therapy on the Platelet Proteome.
Journal: International journal of molecular sciences
Published: June 02, 2021
Hypoxia Impairs Initial Outgrowth of Endothelial Colony Forming Cells and Reduces Their Proliferative and Sprouting Potential.
Journal: Frontiers in medicine
Published: June 18, 2018
A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.
Journal: British journal of cancer
Published: August 01, 2016
Sunitinib activates Axl signaling in renal cell cancer.
Journal: International journal of cancer
Published: October 04, 2015
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 13, 2015
Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics.
Journal: Journal of proteomics
Published: December 29, 2014
Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 03, 2014
Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature.
Journal: Oncoscience
Published: November 12, 2014
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.
Journal: Journal of extracellular vesicles
Published: August 06, 2014
Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026